J.P. Morgan Remains a Buy on UnitedHealth Group (UNH) With a $310 PT

UnitedHealth Group Incorporated (NYSE:UNH) is one of the top most profitable NYSE stocks to buy now. J.P. Morgan analyst Lisa Gill maintained a Buy rating on UnitedHealth Group Incorporated (NYSE:UNH) on August 6, setting a price target of $310.00.

UnitedHealth Group Incorporated (NYSE:UNH) reported in its fiscal Q2 2025 earnings that it is updating its 2025 outlook, expecting revenues in the $445.5 billion to $448.0 billion range and net earnings of at least $14.65 per share.

The revised outlook also includes adjusted earnings of at least $16.00 per share and reflects performance in the first half of the year, along with expectations for the second. Management stated that it also includes higher realized and expected care trends.

UnitedHealth Group Incorporated (NYSE:UNH) expects to return to earnings growth in 2026. The company’s Q2 2025 earnings were $3.74 per share, while adjusted earnings were $4.08 per share.

UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.